Comparing the Use of Topical Therapy Along with Anti-IL-17 and Anti-IL-23 to Treat Moderate-to-Severe Psoriasis in the Routine Clinical Practice S. Berenguer-Ruiz, M. Romero-Dávila, M. Aparicio-Domínguez, M. Olivares-Guerrero, E. Daudén, M. Llamas-Velasco

Application of the Simplified Psoriasis Index in the Routine Clinical Practice: A Pilot Study A. Vidal Ruiz, Á. Sánchez Leiro, N. Eirís Salvado, A.M. Carrizosa Esquivel, D. Moreno Ramírez

Comment on “Drug survival analysis is not a good method for assessing the safety or effectiveness of systemic therapies in psoriasis” J.M.P.A. van den Reek, W. Kievit, E.M.G.J. de Jong